FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022085715> ?p ?o ?g. }

• W2022085715 endingPage "27" @default.
• W2022085715 startingPage "27" @default.
• W2022085715 abstract "A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine Rahul Bhambri,1 Jack Mardekian,1 Larry Z Liu,1,2 Edward Schweizer,3 Elodie Ramos1 1Pfizer, Inc., 2Weill Medical College of Cornell University, New York, NY, USA; 3Paladin Consulting Group, Princeton, NJ, USAAbstract: Migraine is a commonly occurring, chronic disorder that can cause significant disability. Eletriptan, a selective serotonin 5-hydroxytryptamine 1 receptor subtype B/D (5-HT1B/1D) agonist, is a clinically effective treatment for moderate to severe migraine. The objective of this literature review was to summarize the available data on the pharmacoeconomics of eletriptan relative to other triptans. Articles meeting the following three criteria were included in the review: 1) contained pharmacoeconomic data on a marketed dose of eletriptan; 2) included data on at least one other comparator triptan; and 3) was in English. A MEDLINE® search yielded a total of eight studies (from the European Union [n=5] and from the USA [n=3]) across multiple regions. Seven of the studies examined the pharmacoeconomics of eletriptan relative to other triptans, and a further study examined the health care costs of eletriptan 40 mg versus sumatriptan 100 mg. Eletriptan 40 mg was among a group of triptans, including rizatriptan 10 mg and almotriptan 12.5 mg, demonstrating the greatest cost-effectiveness. This result held across different definitions of efficacy (2 hours pain-free, sustained pain-free, and sustained pain-free with no adverse events) and also held when cost-effectiveness models accounted for second doses and use of rescue medication, management of adverse events, and productivity loss, in addition to drug acquisition costs. Only limited head-to-head comparator data were available. The majority of pharmacoeconomic studies utilized the same set of efficacy and/or tolerability data, and indirect costs were rarely included despite the fact that the majority of per capita migraine costs are attributable to indirect costs. In summary, although the market is now dominated by generics, eletriptan 40 mg is among the most clinically and cost-effective oral triptans available for the management of acute migraine. Increased effectiveness/efficacy of eletriptan may necessitate a lesser need for other migraine treatments and/or switching to other triptans.Keywords: oral triptans, cost-effectiveness, literature search" @default.
• W2022085715 created "2016-06-24" @default.
• W2022085715 creator A5023181172 @default.
• W2022085715 creator A5029389400 @default.
• W2022085715 creator A5045558489 @default.
• W2022085715 creator A5054571533 @default.
• W2022085715 creator A5091485152 @default.
• W2022085715 date "2015-01-01" @default.
• W2022085715 modified "2023-09-25" @default.
• W2022085715 title "A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine" @default.
• W2022085715 cites W1793427412 @default.
• W2022085715 cites W184065427 @default.
• W2022085715 cites W1982630387 @default.
• W2022085715 cites W1983983524 @default.
• W2022085715 cites W2006145844 @default.
• W2022085715 cites W2008055993 @default.
• W2022085715 cites W2013033676 @default.
• W2022085715 cites W2014560944 @default.
• W2022085715 cites W2020856081 @default.
• W2022085715 cites W2021523926 @default.
• W2022085715 cites W2025227391 @default.
• W2022085715 cites W2027261838 @default.
• W2022085715 cites W2030153745 @default.
• W2022085715 cites W2047455969 @default.
• W2022085715 cites W2047700866 @default.
• W2022085715 cites W2050659421 @default.
• W2022085715 cites W2054233983 @default.
• W2022085715 cites W2061923792 @default.
• W2022085715 cites W2075393226 @default.
• W2022085715 cites W2078342884 @default.
• W2022085715 cites W2082701466 @default.
• W2022085715 cites W2083727172 @default.
• W2022085715 cites W2084284987 @default.
• W2022085715 cites W2086126627 @default.
• W2022085715 cites W2088104181 @default.
• W2022085715 cites W2091254456 @default.
• W2022085715 cites W2096883662 @default.
• W2022085715 cites W2097858046 @default.
• W2022085715 cites W2098204210 @default.
• W2022085715 cites W2119011129 @default.
• W2022085715 cites W2123225597 @default.
• W2022085715 cites W2126194551 @default.
• W2022085715 cites W2135863583 @default.
• W2022085715 cites W2137516818 @default.
• W2022085715 cites W2141137381 @default.
• W2022085715 cites W2153137999 @default.
• W2022085715 cites W2155231189 @default.
• W2022085715 cites W2167411996 @default.
• W2022085715 cites W2336580589 @default.
• W2022085715 cites W2414452621 @default.
• W2022085715 cites W2769724041 @default.
• W2022085715 cites W48338217 @default.
• W2022085715 doi "https://doi.org/10.2147/ijgm.s73673" @default.
• W2022085715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4296958" @default.
• W2022085715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25624770" @default.
• W2022085715 hasPublicationYear "2015" @default.
• W2022085715 type Work @default.
• W2022085715 sameAs 2022085715 @default.
• W2022085715 citedByCount "5" @default.
• W2022085715 countsByYear W20220857152016 @default.
• W2022085715 countsByYear W20220857152020 @default.
• W2022085715 countsByYear W20220857152022 @default.
• W2022085715 countsByYear W20220857152023 @default.
• W2022085715 crossrefType "journal-article" @default.
• W2022085715 hasAuthorship W2022085715A5023181172 @default.
• W2022085715 hasAuthorship W2022085715A5029389400 @default.
• W2022085715 hasAuthorship W2022085715A5045558489 @default.
• W2022085715 hasAuthorship W2022085715A5054571533 @default.
• W2022085715 hasAuthorship W2022085715A5091485152 @default.
• W2022085715 hasBestOaLocation W20220857151 @default.
• W2022085715 hasConcept C126322002 @default.
• W2022085715 hasConcept C170493617 @default.
• W2022085715 hasConcept C177713679 @default.
• W2022085715 hasConcept C2776738588 @default.
• W2022085715 hasConcept C2777030092 @default.
• W2022085715 hasConcept C2777119127 @default.
• W2022085715 hasConcept C2778541695 @default.
• W2022085715 hasConcept C2778871607 @default.
• W2022085715 hasConcept C2778938600 @default.
• W2022085715 hasConcept C2779085531 @default.
• W2022085715 hasConcept C42219234 @default.
• W2022085715 hasConcept C71924100 @default.
• W2022085715 hasConcept C98274493 @default.
• W2022085715 hasConceptScore W2022085715C126322002 @default.
• W2022085715 hasConceptScore W2022085715C170493617 @default.
• W2022085715 hasConceptScore W2022085715C177713679 @default.
• W2022085715 hasConceptScore W2022085715C2776738588 @default.
• W2022085715 hasConceptScore W2022085715C2777030092 @default.
• W2022085715 hasConceptScore W2022085715C2777119127 @default.
• W2022085715 hasConceptScore W2022085715C2778541695 @default.
• W2022085715 hasConceptScore W2022085715C2778871607 @default.
• W2022085715 hasConceptScore W2022085715C2778938600 @default.
• W2022085715 hasConceptScore W2022085715C2779085531 @default.
• W2022085715 hasConceptScore W2022085715C42219234 @default.
• W2022085715 hasConceptScore W2022085715C71924100 @default.
• W2022085715 hasConceptScore W2022085715C98274493 @default.
• W2022085715 hasLocation W20220857151 @default.
• W2022085715 hasLocation W20220857152 @default.

• next